Laronib 100mg Larotrectinib Capsule In Pakistan | 03289411929

Laronib 100mg contains larotrectinib, a targeted anticancer medicine known as a TRK inhibitor. It is used for adults and children with solid tumors that have an NTRK gene fusion, particularly when the cancer is metastatic, surgery would cause significant morbidity, or there are no satisfactory alternative treatments. Treatment selection requires confirmation of the NTRK fusion through an appropriate diagnostic test.

Specifications:

• Active Ingredient: Larotrectinib
• Strength: 100mg
• Dosage Form: Capsule
• Drug Class: TRK kinase inhibitor
• Route: Oral
• Indication: NTRK fusion-positive solid tumors
• Capsule Strengths: 25mg and 100mg are available formulations.

Benefits:

Larotrectinib specifically targets proteins produced by NTRK gene fusions, which can drive the growth of certain tumors. By inhibiting TRK signaling, it can help slow or control tumor growth in appropriately selected patients. Its use is based on the tumor's molecular characteristics rather than simply the location or type of cancer.

How to Use:

Take Laronib exactly as prescribed by an oncologist. The FDA-labeled adult and pediatric dose for patients with a body-surface area of at least 1 m² is 100mg twice daily; smaller pediatric patients receive a weight/body-surface-area-based dose. Capsules should be swallowed whole with water and should not be crushed or chewed. The dose may need adjustment for liver impairment, adverse reactions, or interactions with certain medicines.